Cambodia becomes the second country in the Asia Pacific to offer long-acting PrEP
Borey and Sophia are among the first clients in Cambodia to begin long-acting injectable Cabotegravir (CAB-LA), a PrEP formulation administered every two months. With this initiative, Cambodia has become a frontrunner in the Asia Pacific region to roll out long-acting PrEP.
Despite progress, HIV stigma and discrimination continue to bubble beneath the surface in Thailand
The Thailand Stigma Index 2.0 study was launched in early March to commemorate Zero Discrimination Day. It shows that despite a strong national HIV response, challenges continue to simmer below the surface.
Impact of US funding cuts on HIV programmes in Vietnam
Impact of US funding cuts on HIV programmes in Vietnam
Status of HIV Programmes in Indonesia
Indonesia has had to pause many programmes due to the U.S. funding freeze. All community led activities funded through USAID have been paused and prevention and linkages to treatment for around 30% of men who have sex with men (MSM) in Jakarta have been affected. In addition, the expansion of PrEP programmes and a test pilot of long-acting HIV pre-exposure prophylaxis (PrEP) have been halted for now.
Lost and link: Indonesian initiative to find people living with HIV who stopped their treatment
Grabbing his helmet, Hadi Timotius gets in the back of his colleague’s scooter to pay a routine visit to a woman who is taking her HIV treatment again. Hadi oversees the ‘Lost and Link’ initiative at JIP, a national network of people living with HIV in Indonesia.
PrEP for her: Cambodia, Indonesia, Papua New Guinea and the Philippines prepare to introduce the Dapivirine ring to help prevent HIV
The Dapivirine Vaginal Ring or DVR was given the green light by the World Health Organization for women at high risk of contracting HIV in 2021. Unlike other types of pre-exposure prophylaxis (PrEP), this one is exclusively for women. It is a silicone vaginal ring that is inserted and worn for 28 days before being replaced. It releases an antiretroviral drug locally, reducing the risk of HIV infection through vaginal sex by half.
New Asia Pacific healthcare provider toolkit serves people having chemsex
Several countries in the region are facing an HIV prevention crisis with new infections among MSM either increasing or decreasing far too slowly. In 2023, 43% of new infections in Asia-Pacific were among MSM. At the same time, there is evidence that the practice of chemsex in this community ranges from 3% to 31% depending on the country. But although chemsex is most visible in the MSM community, it is practiced by people from all populations.
Can this innovation change the way people think about HIV?
In 2020, a gay Thai man living with HIV sparked controversy with a Facebook post. He was on antiretroviral therapy and had gotten lab tests to check the level of virus in his blood. Since his viral load was undetectable, he wrote, he was going to stop using condoms.
Women living with HIV in China unite to confront discrimination
There are around 1.4 million people living with HIV in China and women make up around 23.7% of them, according to the latest data from Chinese health authorities. Among those living with HIV are pregnant women who are in a particularly vulnerable position due to the stigma surrounding the disease
A transformative journey: Parisa's decades-long battle against HIV stigma and discrimination
Undeterred by adversity, Parisa embarked on a relentless mission for human rights, determined to combat the pervasive stigma and discrimination surrounding HIV. Initially, she immersed herself in seminars and conferences, volunteering tirelessly at counselling centres, where she shared her own experiences to chip away at the stigma and discrimination.
